Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Alexander Hattoum"'
Autor:
Edward J Spangenthal, Igor Puzanov, Marc S Ernstoff, Pankit Vachhani, Fumito Ito, Ankita Kapoor, Benjamin Switzer, Poornima Subramanian, Yan V Yatsynovich, David M Jacobs, Maya R Chilbert, Umesh C Sharma, Steven G Feuerstein, Filip Stefanovic, Mark D Hicar, Anne B Curtis, Grace K Dy, Brian J Page, Nikhil Agrawal, Arjun Khunger, Alexander Hattoum, Jerome J Schentag
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background Immune checkpoint inhibitors (ICI) have emerged as a front-line therapy for a variety of solid tumors. With the widespread use of these agents, immune-associated toxicities are increasingly being recognized, including fatal myocarditis. Th
Externí odkaz:
https://doaj.org/article/26e58c0f16aa4f4d82e356fda713f180
Autor:
Nikhil Agrawal, Arjun Khunger, Pankit Vachhani, Teresa A. Colvin, Alexander Hattoum, Edward Spangenthal, Anne B. Curtis, Grace K. Dy, Marc S. Ernstoff, Igor Puzanov
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 1, Pp 260-276 (2019)
The development of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of patients with advanced stage cancers. However, immune-related adverse events are frequently observed. Cardiac toxicity from ICI therapy can range from asymptom
Externí odkaz:
https://doaj.org/article/050b36a63cac4605ad2f222a88150cca
Autor:
Pankit Vachhani, Yan Yatsynovich, Igor Puzanov, Umesh C. Sharma, Edward Spangenthal, Arjun Khunger, Ankita Kapoor, Anne B. Curtis, Maya R. Chilbert, Nikhil Agrawal, Schentag J Jerome, Filip Stefanovic, Benjamin Switzer, Poornima Subramanian, Grace K. Dy, David M. Jacobs, Mark D. Hicar, Alexander Hattoum, Fumito Ito, Marc S. Ernstoff, Steven Feuerstein, Brian J Page
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundImmune checkpoint inhibitors (ICI) have emerged as a front-line therapy for a variety of solid tumors. With the widespread use of these agents, immune-associated toxicities are increasingly being recognized, including fatal myocarditis. The
Autor:
Pankit Vachhani, Alexander Hattoum, Arjun Khunger, Teresa A. Colvin, Marc S. Ernstoff, Grace K Dy, Nikhil Agrawal, Edward Spangenthal, Igor Puzanov, Anne B. Curtis
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 12, Iss 1, Pp 260-276 (2019)
Case Reports in Oncology, Vol 12, Iss 1, Pp 260-276 (2019)
The development of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of patients with advanced stage cancers. However, immune-related adverse events are frequently observed. Cardiac toxicity from ICI therapy can range from asymptom
Publikováno v:
Heart Rhythm. 18:S458-S459
Publikováno v:
Journal of the American College of Cardiology. 71:2041-2057
Advances in medical care have led to an increase in the number of octogenarians and even older patients, forming an important and unique patient subgroup. It is clear that advancing age is an independent risk factor for the development of most arrhyt
Publikováno v:
Heart Rhythm. 18:S385
Autor:
Alexander Hattoum, Matthew T. Heller
Publikováno v:
Emergency Radiology. 19:527-533
For patients with diabetes, insulin therapy can be an effective treatment for years. However, many diabetics eventually develop complications from the disease, including neuropathy, amputations, atherosclerosis, and kidney failure. While kidney failu
Autor:
Alexander Hattoum, Matthew T. Heller
Publikováno v:
Emergency Radiology. 19:329-339
Liver imaging primarily consists of evaluating the parenchyma and biliary system. However, the liver has a rich, complex vascularity which can also be affected by numerous disease processes. By considering disease processes that primarily affect the
Publikováno v:
Journal of the American College of Cardiology. 71:A2582
Supernormal conduction(SNC) is a rare phenomenon where intermittent narrow QRS complexes can occur despite underlying bundle branch block(BBB) at a slower rate. Cellularly, this occurs if the ventricular rate is just beyond the effective refractory p